EGFR and pachyonychia congenita: Recent studies have showed that miR-219-1-3p and targeting epidermal growth factor receptor (EGFR) - signal transduction and activation of transcription-1 (STAT1) axis decreased the expression of MUC4 in PC [43, 44].